(Q37277977)

19 August 2017

1 reference

title

Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated? (English)

1 reference

19 August 2017

Pamela J Hodul

1

1 reference

19 August 2017

Jonathan R Strosberg

series ordinal

2

1 reference

19 August 2017

Larry K Kvols

series ordinal

3

1 reference

19 August 2017

publication date

1 October 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

15

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

314-321

1 reference

Endocrine tumours of the pancreas

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Hepatic neuroendocrine metastases: does intervention alter outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Resection of pancreatic neuroendocrine tumors: results of 70 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Surgery in malignant pancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Aggressive resection of metastatic disease in selected patients with malignant gastrinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Is surgery indicated for patients with symptomatic nonfunctioning pancreatic neuroendocrine tumor and unresectable hepatic metastases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Ablative therapies for liver metastases of digestive endocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

The management of patients with advanced carcinoid tumors and islet cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Karnofsky memorial lecture. An odyssey in the land of small tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Islet cell carcinoma of the pancreas presenting as bleeding from isolated gastric varices. Report of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Pancreatic islet cell tumor presenting as bleeding gastric varices secondary to splenic vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Curative surgery after neoadjuvant chemotherapy in metastatic poorly differentiated neuroendocrine carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Malignant nonfunctioning endocrine tumors of the pancreas: predictive factors for survival after surgical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480801500406

10.1177/107327480801500406

21 January 2018

Identifiers

DOI

0 references

1 reference